Objective To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant
outpatients with type 1 diabetes. Design Systematic review and meta-analysis of …

The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved
glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose-…

Background In persons with type 1 diabetes and high glycated hemoglobin levels, the benefits
of intermittently scanned continuous glucose monitoring with optional alarms for high and …

Diabetes has been identified as a pre-existing health condition linked with worse outcomes
following coronavirus disease 2019 infection. Here we explore the association between …

Background The feasibility, safety, and efficacy of prolonged use of an artificial beta cell (closed-loop
insulin-delivery system) in the home setting have not been established. Methods In …

Background The achievement of glycaemic control remains challenging for patients with
type 1 diabetes. We assessed the effectiveness of day-and-night hybrid closed-loop insulin …

Physical exercise is an important component in the management of type 1 diabetes across
the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of …

OBJECTIVE To evaluate feasibility, safety, and efficacy of overnight closed-loop insulin
delivery in free-living youth with type 1 diabetes. RESEARCH DESIGN AND METHODS …

OBJECTIVE Type 2 diabetes is associated with insulin resistance and skeletal muscle
mitochondrial dysfunction. We have found that subjects with early-onset type 2 diabetes show …

OBJECTIVE To assess associations between current use of sodium–glucose cotransporter
2 inhibitors (SGLT2is), glucagon-like peptide 1 receptor agonists (GLP-1RAs), and their …